Lv6
1654 积分 2024-03-27 加入
Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials
2天前
已关闭
JAK inhibitors for the treatment of autoimmune and inflammatory diseases
3天前
已完结
Tyrosine kinase 2 inhibitors in autoimmune diseases
3天前
已完结
TYK2: an emerging therapeutic target in rheumatic disease
3天前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
3天前
已完结
Early psoriatic arthritis: clinical and therapeutic challenges
3天前
已完结
Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial
4天前
已关闭
One-year outcomes of the treat-and-extend regimen using aflibercept for the treatment of diabetic macular edema
4天前
已完结
NEUROMYELITIS OPTICA SPECTRUM DISORDER IN LATIN AMERICA: a global data share initiative
5天前
已关闭
Interleukin-6 in neuroimmunological disorders: Pathophysiology and therapeutic advances with satralizumab
5天前
已完结
中国心肌病综合管理指南 2025
12天前
已采纳
中国心肌病综合管理指南2025
12天前
已采纳
皖公网安备34019202002308
